AMG-706;MOTESANIB
Compound with spectra: 1 NMR
| SpectraBase Compound ID | JAOydpj0UGA |
|---|---|
| InChI | InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28) |
| InChIKey | RAHBGWKEPAQNFF-UHFFFAOYSA-N |
| Mol Weight | 373.46 g/mol |
| Molecular Formula | C22H23N5O |
| Exact Mass | 373.19026 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
3'-chloro-2'-methyl-2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinanilide
4'-CHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)-o-NICOTINOTOLUIDIDE
2',3'-DICHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)-2',3'-NICOTINOXYLIDIDE
5'-CHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)-o-NICOTINOTOLUIDIDE
2',5'-DICHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
2'-NITRO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
IMATINIB
N,N'-(1,4-phenylene)bis(2-amino-5-cyano-6-phenylnicotinamide)
2-Chloro-N-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]nicotinamide
| Title | Journal or Book | Year |
|---|---|---|
| In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans | Drug Metabolism and Disposition | 2009 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.
KnowItAll Mass Spectral Library
Author: Wiley
The KnowItAll Mass Spectral Library offers a comprehensive collection of mass spectra, including the renowned Wiley Registry, and access to a wide range of compounds including pure organics, drugs, steroids, additives, geochemicals, petrochemicals, biomarkers, and more. Learn more.